GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Patterson Companies Inc (NAS:PDCO) » Definitions » Debt-to-EBITDA

Patterson (Patterson) Debt-to-EBITDA : 2.33 (As of Jan. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Patterson Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Patterson's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $366 Mil. Patterson's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $529 Mil. Patterson's annualized EBITDA for the quarter that ended in Jan. 2024 was $384 Mil. Patterson's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 was 2.33.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Patterson's Debt-to-EBITDA or its related term are showing as below:

PDCO' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.43   Med: 2.26   Max: 3.28
Current: 2.33

During the past 13 years, the highest Debt-to-EBITDA Ratio of Patterson was 3.28. The lowest was -1.43. And the median was 2.26.

PDCO's Debt-to-EBITDA is ranked worse than
54.67% of 75 companies
in the Medical Distribution industry
Industry Median: 1.87 vs PDCO: 2.33

Patterson Debt-to-EBITDA Historical Data

The historical data trend for Patterson's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Patterson Debt-to-EBITDA Chart

Patterson Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.28 -1.43 2.38 1.60 1.62

Patterson Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.85 1.20 2.34 2.22 2.33

Competitive Comparison of Patterson's Debt-to-EBITDA

For the Medical Distribution subindustry, Patterson's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Patterson's Debt-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Patterson's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Patterson's Debt-to-EBITDA falls into.



Patterson Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Patterson's Debt-to-EBITDA for the fiscal year that ended in Apr. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(109.39 + 518.607) / 387.501
=1.62

Patterson's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(366.262 + 528.718) / 384.108
=2.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jan. 2024) EBITDA data.


Patterson  (NAS:PDCO) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Patterson Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Patterson's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Patterson (Patterson) Business Description

Traded in Other Exchanges
Address
1031 Mendota Heights Road, Saint Paul, MN, USA, 55120
Patterson Companies Inc is a leading dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives a majority of its revenue from the United States.
Executives
Kevin Michael Barry officer: Chief Financial Officer 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Donald Zurbay officer: Chief Financial Officer C/O ST. JUDE MEDICAL, INC., ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117
Timothy E Rogan officer: President - Dental 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Les B Korsh officer: VP, General Counsel 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55110
Meenu Agarwal director 7246 E MERCER WAY, MERCER ISLAND WA 98040
Samantha L Bergeson officer: CHRO 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Andrea L. Frohning officer: Chief Human Resources Officer C/O DENTSLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Philip Mckoy director 120 BROADWAY, SUITE 200, SANTA MONICA CA 90401
Jody H Feragen director 1 HORMEL PLACE, AUSTIN TX 55912
Eric R Shirley officer: President-Patterson Dental 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Francis Joseph Malecha director 9900 WEST 109TH STREET, SUITE 100, OVERLAND PARK KS 66210
Robert Frenzel director 414 NICOLLET MALL, MINNEAPOLIS MN 55401
Dennis W Goedken officer: Interim CFO 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Ann B Gugino officer: Vice President 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
John D Buck director 4201 GULF SHORE BLVD NORTH, APT 1703N, NAPLES FL 34103

Patterson (Patterson) Headlines

From GuruFocus

Patterson Enters Agreement to Acquire Dairy Tech

By Business Wire Business Wire 11-14-2022

Patterson Companies Announces Leadership Transition

By Business Wire Business Wire 10-13-2022

Patterson Companies Declares Regular Quarterly Cash Dividend

By Business Wire Business Wire 03-15-2022

Patterson Companies Inc's Dividend Analysis

By GuruFocus Research 01-17-2024

Patterson Companies Elects Meenu Agarwal to Board of Directors

By Business Wire Business Wire 06-15-2023

Patterson Closes Acquisition of Dairy Tech

By Business Wire Business Wire 12-12-2022